This announcement is a separate document:
康美药业董事会关于独立董事2023年度独立性的专项评估意见
Special evaluation opinion of the board of directors of Kangmei Pharmaceutical on the independence of independent directors in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.